Clinical Trial Update: A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating TNF and ENT in improving long-term prognosis after curative resection for hepatitis B-related hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma Recurrent

Drugs mentioned

• TNF and ENT

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma Recurrent | Phase 3 | Status: UNKNOWN